Navigation Links
FDA, NIH and Genzyme Reveal Their Strategies to Overcome Viral Contamination at the Pathogen Safety Summit
Date:9/5/2012

LONDON, September 6, 2012 /PRNewswire/ --

Leading biotech and biopharma organisations are coming together to learn how to maximise their viral security strategies and the new technologies available from the FDA, NIBSC, NIH and a range of industry experts including Genzyme, Baxter and Amgen  at the Pathogen Safety Summit this November.

Pharma IQ's Pathogen Safety Summit is back for its third year to offer the opportunity to learn and hear insights from key regulatory bodies, industry representatives and experts in viral safety on the current viral security strategies and technologies.

As the cost of contamination is huge, both financially and to an organisation's reputation, this event will cover:

  • The latest regulatory updates on viral safety from Arifa Khan, FDA and Dr Wahiba Oualikene-Gonin, AFSAAPS
  • James Gilbert, Biogen Idec and  Lada Laenen, Genzyme,  will share  best practices for the successful evaluation of raw materials
  • Knowledge of the most prevalent pathogens currently being found in biologics from Phil Minor, NIBSC
  • Adam Polermo, Genzyme, present the latest data on the implementation of deep sequencing technologies
  • Rebecca Sheets, NIH, streamlines the viral screening process and rationalise the implementation of the latest technologies

This interactive, senior-level summit will allow organisations to benchmark themselves against the leading experts in biosafety.

Find the full program, event details and registration information at http://www.pathogensafetysummit.com/news, call +44(0)20-7036-1300 or email enquire@iqpc.co.uk.  

Media contact: Nishkala Thiru, +44(0)20-7368-9725, Nishkala.Thiru@iqpc.co.uk or visit http://www.pathogensafetysummit.com/news.

Press are invited to attend this important industry forum, if you would like a complimentary press pass please email Nishkala Thiru at Nishkala.Thiru@iqpc.co.uk    



'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Magnetic vortex reveals key to spintronic speed limit
2. The Insider Secrets of Back Pain Treatment Revealed
3. Martha Stewart Reveals the Secret Behind her Radiant Skin is Revolutionary Anti-aging BIOEFFECT EGF SERUM
4. Researchers reveal why some pain drugs become less effective over time
5. ORNL microscopy reveals atomic antenna behavior in graphene
6. Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin
7. Graphene reveals its magnetic personality
8. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
9. Imprisoned molecules quantum rattle in their cages
10. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
11. Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMAs Fully Human Antibody Libraries for Their Discovery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , November 30, 2016 The global ... few players hold a dominant share in the overall ... Laboratories International, Inc., and Merck KGaA, held a lion,s ... Transparency Market Research observes that these companies are expected ... development products that are do not require rabbit pyrogen ...
(Date:11/30/2016)... VANCOUVER , Nov. 30, 2016 /PRNewswire/ -  Equicare ... coordination solutions, has been recognized as one of the ... 100, an annual international listing that distinguishes the top ... "We,ve pushed a great step forward this year continually ... growing our own customer base and team," says ...
(Date:11/30/2016)... -- Part of 5m$ Investment in Integrated Drug ... , ... today announced that it had successfully completed the expansion of ... increased the Screening Collection to over 400,000. The new compounds ... the company. This expansion, complemented by new robotics and compound ...
(Date:11/30/2016)... Triangle Park, NC (PRWEB) , ... November 30, ... ... development company engaged in the development of a new orally administered treatment for ... testing and neuroimaging results of a Phase 2a clinical trial of T3D-959 in ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):